THNR ETF

THNR ETF
$24.17
See how much of THNR you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

LLY is THNR's largest holding at 10.19% of the fund as of Oct 1, 2026. THNR is Amplify Weight Loss Drug & Treatment ETF.

Showing top 23 of 23 holdings · as of Oct 1, 2026
THNR holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
LLY
Eli Lilly & Co.Health Care · Pharmaceuticals
10.19%		10.2%503$578.4KHealth CarePharmaceuticals
2—Novo-Nordisk A/S-Spons AdrHealth Care · Pharmaceuticals
8.45%		18.6%12,835$480.0KHealth CarePharmaceuticals
Sector and industry · Pro
3—CSPC Pharmaceutical Group Limited Shs
5.92%		24.6%262,000$336.2K
4
AMGN
Amgen Inc.
5.65%		30.2%788$320.9K
5
PFE
Pfizer Inc
5.40%		35.6%10,896$306.4K
6—Innovent Biologics Inc
5.39%		41.0%24,500$306.1K
7—Developed Markets Astrazeneca Plc Sponsored Adr
5.24%		46.2%1,888$297.7K
8—Roche Holding Ag- Genusschein
4.66%		50.9%630$264.7K
9
ABBV
AbbVie Inc.
4.61%		55.5%1,007$261.8K
10
GILD
Gilead Sciences
4.58%		60.1%1,763$260.0K
11
MRK
Merck & Company Inc
4.58%		64.7%1,809$260.2K
12
REGN
Regeneron Pharmaceuticals, Inc.
4.58%		69.3%354$260.1K
13—Chugai Pharmaceutical Co. Ltd. Com Stk
4.55%		73.8%6,600$258.4K
14
VKTX
Viking Therapeutics Inc
4.34%		78.1%8,076$246.4K
15
ARWR
Arrowhead Pharmaceuticals Inc
4.04%		82.2%3,541$229.4K
16
AGPXX
Invesco Government & Agency Portfolio, Institutional Class
3.94%		86.1%223,946$223.9K
17
ZEAL
Zealand Pharma A/s
3.74%		89.9%5,542$212.6K
18—Hanmi Pharm Co Ltd
3.56%		93.4%552$202.2K
19—Structure Therapeutics Inc Adr
3.11%		96.5%6,098$176.7K
20—Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
2.41%		98.9%21,400$136.9K
21
KLRA
Kailera Therapeutics Inc
0.97%		99.9%4,979$54.9K
22—Other Assets and Liabilities
0.08%		100.0%321,398,679$4.4K
23—USD
0.00%		100.0%213$213
Not reported for this fund: share changes.
FundXLS Pro
See every sector, industry and share-change value
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

THNR ETF All Holdings

THNR holdings total 45 positions. The top 10 holdings account for 60.1% of the fund, led by Eli Lilly & Co. at 10.2%, Novo-Nordisk A/S-Spons Adr at 8.4%, CSPC Pharmaceutical Group Limited Shs at 5.9%.

THNR portfolio concentration is relatively high, with the top 10 representing 60.1% of total assets. The largest sector exposure is Health Care at 76.1%.

THNR sectors provide a detailed breakdown. THNR overlap shows how holdings compare to other funds in your portfolio.

Compare THNR

THNR vs SPYTHNR vs QQQTHNR vs VOOTHNR vs VTITHNR vs IVVTHNR vs SCHDTHNR vs VYMTHNR vs VXUS

THNR ETF Holdings

23 of 45 holdings

  • 1

    Eli Lilly & Co.

    LLYHealth Care
    10.19%
  • 2

    Novo-Nordisk A/S-Spons Adr

    NVO:OSHealth Care
    8.45%
  • 3

    CSPC Pharmaceutical Group Limited Shs

    1093:HKHealth Care
    5.92%
  • 4

    Amgen Inc.

    AMGNHealth Care
    5.65%
  • 5

    Pfizer Inc

    PFEHealth Care
    5.40%
  • 6

    Innovent Biologics Inc

    1801:HKHealth Care
    5.39%
  • 7

    Developed Markets Astrazeneca Plc Sponsored Adr

    AZN:LNHealth Care
    5.24%
  • 8

    Roche Holding Ag- Genusschein

    RHO5:FFUnknown
    4.66%
  • 9

    Abbvie Inc.

    ABBVHealth Care
    4.61%
  • 10

    Gilead Sciences

    GILDHealth Care
    4.58%
  • 11

    Merck & Company Inc

    MRKHealth Care
    4.58%
  • 12

    Regeneron Pharmaceuticals, Inc.

    REGNHealth Care
    4.58%
  • 13

    Chugai Pharmaceutical Co. Ltd. Com Stk

    4519:JPUnknown
    4.55%
  • 14

    Viking Therapeutics Inc Com

    VKTXHealth Care
    4.34%
  • 15

    Arrowhead Pharmaceuticals Inc

    ARWRHealth Care
    4.04%
  • 16

    Invesco Government & Agency Portfolio, Institutional Class

    AGPXXFinancials
    3.94%
  • 17

    Zealand Pharma A/s

    ZEAL:COUnknown
    3.74%
  • 18

    Hanmi Pharm Co Ltd

    128940:KRUnknown
    3.56%
  • 19

    Structure Therapeutics Inc Adr

    GPCR:SHHealth Care
    3.11%
  • 20

    Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H

    1276:SHUnknown
    2.41%
  • 21

    Kailera Therapeutics Inc

    KLRAUnknown
    0.97%
  • 22

    Other Assets And Liabilities

    Other
    0.08%
  • 23

    USD

    Other
    0.00%